Alector (ALEC) Enterprise Value (2018 - 2026)
Alector (ALEC) reported Enterprise Value of -$206.5 million for Q1 2026, up 41.75% year-over-year from -$145.7 million in Q1 2025, and up 19.34% quarter-over-quarter from -$256.0 million in Q4 2025.
Alector (ALEC) Enterprise Value (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Enterprise Value data on file, last reported at -$206.5 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$206.5 million, up 41.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$206.5 million (up 41.75% YoY), and the FY2025 annual result was -$256.0 million, up 38.07% from the prior year.
- Enterprise Value grew to -$206.5 million in Q1 2026 per ALEC's latest filing, from -$256.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$206.5 million in Q1 2026 and troughed at -$868.6 million in Q1 2022.
- A 5-year average of -$525.7 million and a median of -$548.9 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value slumped 153.11% in 2022, then surged 41.75% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$712.9 million in 2022, then climbed by 23.0% to -$548.9 million in 2023, then climbed by 24.68% to -$413.4 million in 2024, then jumped by 38.07% to -$256.0 million in 2025, then rose by 19.34% to -$206.5 million in 2026.
- Business Quant data shows ALEC's Enterprise Value at -$206.5 million in Q1 2026, -$256.0 million in Q4 2025, and -$291.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -206.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.52 Mn |
| Dec 31, 2025 | -256.02 Mn |
| Sep 30, 2025 | -291.11 Mn |
| Jun 30, 2025 | -307.28 Mn |
| Mar 31, 2025 | -354.55 Mn |
| Dec 31, 2024 | -413.40 Mn |
| Sep 30, 2024 | -457.20 Mn |
| Jun 30, 2024 | -503.33 Mn |
| Mar 31, 2024 | -562.08 Mn |
| Dec 31, 2023 | -548.86 Mn |
| Sep 30, 2023 | -588.86 Mn |
| Jun 30, 2023 | -630.05 Mn |
| Mar 31, 2023 | -669.33 Mn |
| Dec 31, 2022 | -712.85 Mn |
| Sep 30, 2022 | -758.31 Mn |
| Jun 30, 2022 | -808.86 Mn |
| Mar 31, 2022 | -868.57 Mn |
| Dec 31, 2021 | -735.25 Mn |
| Sep 30, 2021 | -777.85 Mn |
| Jun 30, 2021 | -319.57 Mn |